Connect with us


Dr Babafemi Taiwo



Profile & Biography Of Dr Babafemi Taiwo

Real Name Babafemi Taiwo
Age 54yrs
Birthplace Nigeria
Profession Medical Doctor
University University of Ibadan

Who Is Dr Babafemi Taiwo

Meet Dr Babafemi Taiwo he is bright doctor from the West African country of Nigeria.

He is leading part of a major study on antiviral drug Remdesivir appearing to treat COVID-19, the potentially deadly respiratory disease caused by the coronavirus, which has killed more than 200,000 people around the world.


Dr Taiwo did his undergraduate education, and initial medical training took place at the College of Medicine, University of Ibadan and  obtained his (MBBS) degree from the University of Ibadan, Nigeria in 1991.

Postgraduate Training

Resident: Berkshire Medical Center, Internal Medicine (1996)
Fellow: Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital), (2006)

Qualification, Certifications & License of Dr Babafemi Taiwo

Dr Babafemi Taiwo is a Chief of Infectious Diseases in the Department of Medicine & Professor of Medicine (Infectious Diseases)

Chief, Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, Chicago

He is the Director, Clinical Core of the Third Coast Center for AIDS Research, and Leader of the Northwestern University Site of the NIAID-funded AIDS Clinical Trials Group (ACTG).

He is a memeber of the clinical and translational HIV researchers from infectious diseases, hepatology, neurology, radiology, cardiology and nursing, and directs the development and implementation of NIH-sponsored interventional and observational HIV studies at Northwestern University,

He has received research grants (to Northwestern) from industry sponsors for investigator-initiated studies.

For two years, he has been the Director, Research in Africa, NU Center for Global Health. He has been involved in HIV treatment, research and training in Nigeria.

He is currently the Principal Investigator of the NIH D43 Multidisciplinary NeuroAIDS Training and Research Program in Nigeria.


Board Certification: Internal Medicine.

Board Certification: Infectious Disease.

Awards Received By Dr Babafemi Taiwo

John Carey Young Unvestigator Award, ACTG (2009)
External Professional Leadership and Service
Member, Planning Committee ACTHIV 2020 (2019 – Present)
Member, Executive Committee ACTG (2019 – Present)
Member, NIH Office of AIDS Research Advisory Committee (2019 – Present)
Editorships / Editorial Board Service
Editor, Journal Antimicrobial Chemotherapy (2019 – Present)
Scientific or Medical Advisory Board Service
Scientific Advisory Board Member, ViiV Healthcare (2019 – Present)
Scientific Advisory Board Member, Gilead Sciences (2019 – 2019)
Scientific Advisory Board Member, Merck (2019 – 2019)
Professional Society Membership
Member, AIDS Clinical Trials Group of the NIH (2019 – Present)
Member, International AIDS Society (2019 – Present)
Member, Infectious Diseases Society of America (2019 – Present)

Articles Written By Dr Babafemi Taiwo

Most Recent Publications

Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy.
Taiwo Babafemi O, Quiñones-Mateu Miguel E, Smith Kimberly, Zheng Lu, Gulick Roy, Nyaku Amesika N, Sax Paul E, Ha Belinda, Kumwenda Johnstone, Olefsky Maxine, Godfrey Catherine, Wallis Carole
AIDS research and human retroviruses. 2020 Mar;
PMID: 31914799 ISSN: 0889-2229

Limited correlation between systemic biomarkers and neurocognitive performance before and during HIV treatment
Robertson K, Landay A, Miyahara S, Vecchio A, Masters MC, Brown TT, Taiwo BO
Journal of NeuroVirology. 2020 Feb; 26(1): 107-113.
PMID: 31468473 ISSN: 1355-0284

HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-subtype B HIV-1 Infections in Nigeria and Malawi.
Adewumi Olubusuyi Moses, Dukhovlinova Elena, Shehu Nathan Y, Zhou Shuntai, Council Olivia D, Akanbi Maxwell O, Taiwo Babafemi, Ogunniyi Adesola, Robertson Kevin, Kanyama Cecilia, Hosseinipour Mina C, Swanstrom Ronald
AIDS research and human retroviruses. 2020 Feb;
PMID: 31914800 ISSN: 0889-2229


Initial Antiretroviral Therapy in an Integrase Inhibitor Era: Can We Do Better?
Kelly SG, Masters MC, Taiwo BO
Infectious Disease Clinics of North America. 2019 Sep; 33(3): 681-692.
PMID: 31239093 ISSN: 0891-5520

For more of his articles kindly click the reference link Babafemi Taiwo Publications


Reference Links

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


World News

Local News